These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 26057452)

  • 1. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients.
    Summerer I; Unger K; Braselmann H; Schuettrumpf L; Maihoefer C; Baumeister P; Kirchner T; Niyazi M; Sage E; Specht HM; Multhoff G; Moertl S; Belka C; Zitzelsberger H
    Br J Cancer; 2015 Jun; 113(1):76-82. PubMed ID: 26057452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients.
    Summerer I; Niyazi M; Unger K; Pitea A; Zangen V; Hess J; Atkinson MJ; Belka C; Moertl S; Zitzelsberger H
    Radiat Oncol; 2013 Dec; 8():296. PubMed ID: 24373621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiles of miR-29c, miR-200b and miR-375 in tumour and tumour-adjacent tissues of head and neck cancers.
    Hudcova K; Raudenska M; Gumulec J; Binkova H; Horakova Z; Kostrica R; Babula P; Adam V; Masarik M
    Tumour Biol; 2016 Sep; 37(9):12627-12633. PubMed ID: 27440205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
    Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
    Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.
    Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K
    Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma.
    Panvongsa W; Siripoon T; Worakitchanon W; Arsa L; Trachu N; Jinawath N; Ngamphaiboon N; Chairoungdua A
    Cancer Sci; 2021 Oct; 112(10):4257-4269. PubMed ID: 34273216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
    PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary MicroRNAs for Early Detection of Head and Neck Squamous Cell Carcinoma: A Case-Control Study in the High Altitude Mestizo Ecuadorian Population.
    Salazar-Ruales C; Arguello JV; López-Cortés A; Cabrera-Andrade A; García-Cárdenas JM; Guevara-Ramírez P; Peralta P; Leone PE; Paz-Y-Miño C
    Biomed Res Int; 2018; 2018():9792730. PubMed ID: 30584540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection.
    Karasek P; Gablo N; Hlavsa J; Kiss I; Vychytilova-Faltejskova P; Hermanova M; Kala Z; Slaby O; Prochazka V
    Cancer Genomics Proteomics; 2018; 15(4):321-327. PubMed ID: 29976637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
    Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
    Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
    Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
    J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Tumor Suppressive Genes Regulated by
    Oshima S; Asai S; Seki N; Minemura C; Kinoshita T; Goto Y; Kikkawa N; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unpredictable changes of selected miRNA in expression profile of HNSCC.
    Lamperska KM; Kozlowski P; Kolenda T; Teresiak A; Blizniak R; Przybyla W; Masternak MM; Golusinski P; Golusinski W
    Cancer Biomark; 2016; 16(1):55-64. PubMed ID: 26484611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-200b and miR-155 as predictive biomarkers for the efficacy of chemoradiation in locally advanced head and neck squamous cell carcinoma.
    Hess AK; Müer A; Mairinger FD; Weichert W; Stenzinger A; Hummel M; Budach V; Tinhofer I
    Eur J Cancer; 2017 May; 77():3-12. PubMed ID: 28347920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
    Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
    J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.